ClinicalTrials.gg
RecruitingNCT05719935Updated Nov 15, 2023

The KinematX Midcarpal Total Wrist Arthroplasty Registry

An observational study in Scapholunate Advanced Collapse (SLAC), Scapholunate Crystalline Advanced Collapse (SCAC) and Scaphoid, Trapezium, and Trapezoid Advanced Collapse (STTAC), sponsored by Extremity Medical. Recruiting at 4 sites in United States. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2023-11-15.

Sponsored by Extremity Medical · Observational

How we know

From the registry’s dates

  • Started Apr 2021; still recruiting 5 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
18 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 97 studies in Carpal Tunnel Syndrome with a site in United States — 10 open to participants now, 12 under way, none of them phase 3. Carpal Tunnel Syndrome · United States.

Planned enrollment
16th of 24
50 · median 107
Started
2021
with 6 others
Observational
24 of 97
1 open now
Primary completion
2035-12
later than 11 of 11 live
Registered
84th of 97
by date

Among the 97 studies in Carpal Tunnel Syndrome with a site in United States, this one is the 16th largest by planned enrollment of the 24 observational ones that give a count, is one of 7 that started in 2021, is one of 24 observational ones, reaches primary completion later than 11 of the 11 other live ones, and was the 84th registered.

Carpal Tunnel Syndrome

591 studies on the registry are indexed under Carpal Tunnel Syndrome; 133 are open to participants now.

Browse Carpal Tunnel Syndrome studies →

Open to participants now

10 of the 97 studies in Carpal Tunnel Syndrome with a site in United States are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 72 Carpal Tunnel Syndrome studies recruiting now, 27 (38%) set no upper age limit and 36 (50%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.

This study: 18 Years to 85 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 97 studies in Carpal Tunnel Syndrome with a site in United States, or all of them as a file.
02

Study summary

The goal of this observational study is to learn about functional and patient reported outcomes in patient undergoing total wrist replacement with the KinematX total wrist replacement study.

The main questions it aims to answer are:

  • What is the range of motion (flexion, extension, radial, ulnar, grip and pinch strength) at 3-, 6-, and 12-months after surgery and yearly up to 10 years among patients having total wrist replacement with the KinematX implant.
  • What are the patient reported outcomes (PROMIS, PRWE, HSS wrist expectations) at 3-, 6-, and 12-months after surgery and yearly up to 10 years among patients having total wrist replacement with the KinematX implant.
  • How do range of motion and patient reported outcomes change over the 10 years after total wrist replacement surgery?

Participants will be followed according to standard of care and preoperative and post-operative information for up to 10 years after surgery will be collected and entered into an electronic data base. Patients are eligible to enroll into the registry before or after they have had their wrist replacement surgery.

03

Conditions studied

  • Scapholunate Advanced Collapse (SLAC)
  • Scapholunate Crystalline Advanced Collapse (SCAC)
  • Scaphoid, Trapezium, and Trapezoid Advanced Collapse (STTAC)
  • Carpal Tunnel Syndrome (CTS)
  • Kienbock's Disease of Adults
  • Radial Malunion
  • Ulnar Translocation
  • Post Traumatic Arthritis
  • Inflammatory Arthritis
  • Osteoarthritis
  • Scaphoid Non-union Advanced Collapse (SNAC)

Keywords

  • Total wrist replacement
  • Total wrist arthroplasty
04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients aged 18-85 with planned (or previously completed) total wrist arthroplasty with the KinematX total wrist are eligible for enrollment into this study

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • one of the following diagnoses and planned (or previously completed) total wrist arthroplasty with the KinematX total wrist:

    • osteoarthritis or post-traumatic arthritis
    • scapholunate advanced collapse (SLAC/SNAC wrist),
    • inflammatory arthritis (rheumatoid, psoriatic, other),
    • crystalline advanced collapse (SCAC),
    • STT advanced collapse (STTAC),
    • ulnar translocation,
    • Kienbӧck disease,
    • radial malunion

Exclusion criteria

Exclusion Criteria:

  • \<18 years of age
  • >85 years of age
  • Prisoners
  • Children
  • Pregnant women
  • to receiving the KinematX:

    • Local, distant or systematic acute or chronic soft tissue or bony infection
    • Physiologically or psychologically compromised patient
    • Active wrist synovitis or severe carpal bone erosion
    • Suspected or documented metal allergy or intolerance
    • Insufficient extensor tendons
    • Inadequate skin, bone, neural or vascular status
    • Severe carpal bone malalignment, displacement, absorption, neoplastic, or carpal bone pathology
    • Sepsis
    • Osteomyelitis
    • Uncontrolled/untreated osteoporosis or metabolic bone disease
    • Metabolic or endocrinologic bone disorders
    • Osteomalacia
    • Distant foci of infections which may spread to the implant site
    • Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Target follow-up
10 Years
Patient registry
Yes

Groups and cohorts

  • KinematX patients

    Patients undergoing total wrist replacement with the KinematX implant.

    Device: KinematX total wrist arthroplasty system

Interventions

  • DeviceKinematX total wrist arthroplasty system

    The KinematX total wrist implant is a joint metal/polymer semi-constrained cemented prosthesis that utilizes an articulation that mimics the midcarpal joint instead of the radiocarpal joint.

06

What researchers measure

Primary outcomes

  1. Range of Motion (as assessed by physician)

    Flexion, Extension, Ulnar, Radial

    Time frame: Up to 10 years

Secondary outcomes

  1. PROMIS Upper Extremity Physical Function 7a

    7 questions designed to understand the patient's physical function in the upper extremity specifically; population average t-score is 50, with a standard deviation of 10; higher scores are better.

    Time frame: 3 months, 6 months, yearly up to 10 years post-surgery

  2. PROMIS Pain Interference 8a

    8 questions designed to understand how any pain experienced interferes with the patient's day to day life; population average t-score is 50, with a standard deviation of 10; lower scores are better

    Time frame: 3 months, 6 months, yearly up to 10 years post-surgery

  3. PROMIS Global 10

    10 questions to assess the patient's global health with subscales for physical health and mental health; Physical health t-scores range from 16.2 to 67.7; Mental health t-scores range from 21.2 to 67.6; higher scores are better

    Time frame: 3 months, 6 months, yearly up to 10 years post-surgery

  4. Patient-Rated Wrist Evaluation Score (PRWE)

    15 questions that assess pain and function; total scores can range from 0-100; lower scores are better

    Time frame: 3 months, 6 months, yearly up to 10 years post-surgery

  5. Hospital for Special Surgery Wrist Surgery Expectations Survey

    22 questions that assess how the patient expects to benefit from the surgery and a corresponding post-operative instrument that asks about actual experience; score range from 22 to 110; lower scores are better

    Time frame: Pre-operative and yearly up to 10 years post-surgery

  6. Percentage of patients experiencing post-operative complications

    Time frame: 3 months, 6 months, yearly up to 10 years post-surgery

  7. Percentage of patients requiring revision surgery for their implant (with or without implant replacement)

    Time frame: 3 months, 6 months, yearly up to 10 years post-surgery

  8. Grip and pinch strength (as assessed by physician)

    Grip and pinch strength

    Time frame: 3months, 6 months, yearly up to 10 years post-surgery

07

Study locations

4 of 4 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2021 (actual). Primary completion is estimated for Dec 2035, 176 months after the start.

Of 42 observational studies under Carpal Tunnel Syndrome, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 47. This study's planned 176 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 19, 2022
First posted
Feb 9, 2023
StartActual
Apr 26, 2021
Primary completionEst.
Dec 2035
CompletionEst.
Dec 2035
Last update
Nov 15, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 15, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05719935
Lead sponsor
Extremity Medical
Responsible party
Sponsor
First posted
Feb 9, 2023
Start date
Apr 26, 2021
Primary completion
Dec 2035 (estimated)
Completion
Dec 2035 (estimated)
Last update
Nov 15, 2023

Study contacts

Brian Smekal
Contact
bsmekal@extremitymedical.com
+1 952-836-5698
Brian Smekal
study director · Extremity Medical

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion